Equities
Health CareMedical Equipment and Services
  • Price (AUD)24.58
  • Today's Change-0.13 / -0.53%
  • Shares traded261.65k
  • 1 Year change-8.45%
  • Beta0.8016
Data delayed at least 20 minutes, as of Mar 28 2024 05:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ansell Limited is an Australia-based provider of hand and body protection solutions and an integrated manufacturer, innovator and marketer of products. The Company is principally involved in the development, manufacturing and sourcing, distribution and sale of hand and body protection solutions in the industrial and healthcare markets. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Healthcare GBU segment is engaged in surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single-use industrial application gloves. Industrial GBU segment is engaged in multi-use hand and body protection solutions for industrial work environments and specialty applications.

  • Revenue in AUD (TTM)2.46bn
  • Net income in AUD158.91m
  • Incorporated1920
  • Employees14.41k
  • Location
    Ansell LtdLevel 3, 678 Victoria StRICHMOND 3121AustraliaAUS
  • Phone+61 39270-7270
  • Fax+61 39270-7300
  • Websitehttps://www.ansell.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Micro-Tech Nanjing Co Ltd468.67m103.79m2.61bn2.38k25.233.51--5.572.602.6011.7418.690.55391.536.55928,815.2012.3711.2314.6513.6062.6463.0522.3219.344.68--0.017829.521.7225.321.8026.7231.91--
Eyebright Medical Tchnlgy Beijing Co Ltd170.73m60.49m2.72bn871.0045.146.20--15.962.712.717.6419.730.34041.525.06925,695.0011.679.2812.8910.1280.0384.3334.2935.905.52--0.074220.7633.8150.6035.80--53.76--
Fukuda Denshi Co Ltd1.42bn195.26m2.74bn3.38k10.841.219.401.93638.29638.294,642.155,726.010.69193.304.0841,521,290.009.517.5011.269.6053.6145.2713.759.963.31--0.010328.851.930.8796.5513.1410.8814.87
Poly Medicure Ltd.239.61m45.68m2.79bn2.34k61.18--48.8711.6625.9025.90135.86--------5,577,489.00--12.23--15.0665.0355.4519.0615.11--36.95--17.9820.8216.4122.3720.4923.758.45
Shenzhen YHLO Biotech Co Ltd507.49m89.82m2.90bn1.84k32.355.50--5.710.74370.74374.214.370.66622.005.481,304,683.0010.23--13.71--49.90--15.36--1.46--0.2228--237.95--394.46------
Hartalega Holdings Berhad590.19m-104.19m3.05bn7.56k--2.02--5.16-0.0943-0.09430.53411.360.3316--10.54241,379.70-5.9528.94-6.4234.00--46.86-17.9429.874.84-37.130.022646.64-69.450.0331-107.27--3.11--
Shanghai MicroPort Edvcl MdTch Grp CoLtd237.31m94.10m3.06bn786.0028.276.43--12.886.176.1715.5727.150.53721.598.401,425,843.0021.0419.6423.4821.6875.2877.1139.1742.535.27--0.019638.2530.9540.2612.9941.2959.78--
Ansell Ltd2.46bn158.91m3.08bn14.41k19.731.2811.471.261.251.2519.4219.350.63121.848.15170,436.204.136.604.967.8937.9937.836.559.500.947511.460.241842.17-15.212.13-6.554.318.020.8306
Beijing Balance Medical Technolgy Co Ltd70.26m22.37m3.18bn355.00142.1013.01--45.320.77480.77482.438.460.27911.205.18934,697.708.708.359.088.6788.7789.4331.1730.2012.83--0.011551.6017.2126.1685.8217.6551.59--
Shanghai Haohai Biological Technology558.66m88.23m3.23bn2.16k14.931.0824.955.782.652.6516.7536.650.37651.557.371,323,530.005.894.846.865.5070.3472.0915.6516.504.50--0.063536.7625.2711.26130.580.0762--14.27
Data as of Mar 28 2024. Currency figures normalised to Ansell Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

48.12%Per cent of shares held by top holders
HolderShares% Held
Allan Gray (Pty) Ltd.as of 05 Oct 202323.89m18.99%
The Vanguard Group, Inc.as of 29 Dec 20236.67m5.30%
Australian Retirement Trust Pty Ltd.as of 15 Dec 20236.31m5.02%
State Street Global Advisors, Australia, Ltd.as of 09 Mar 20236.12m4.87%
Allan Gray Australia Pty Ltd.as of 31 Dec 20235.84m4.65%
First Sentier Investors (Australia) IM Ltd.as of 24 Jun 20223.45m2.74%
Dimensional Fund Advisors LPas of 07 Mar 20242.90m2.31%
Vanguard Investments Australia Ltd.as of 29 Feb 20242.18m1.74%
Harris Associates LPas of 31 Dec 20231.69m1.35%
BlackRock Fund Advisorsas of 07 Mar 20241.46m1.16%
More ▼
Data from 31 Dec 2023 - 22 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.